Balance Sheet Data
Avidity Biosciences, Inc. (RNA)
$15.35
-1.45 (-8.63%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 3.09 | 94.58 | 328.14 | 405.54 | 610.73 | 1,089.06 | 3,106.16 | 8,859.23 | 25,267.82 | 72,067.53 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | - | - | - | - | - | - | - | - | - | - |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.57 | 2.31 | 7.74 | 19.48 | 19.26 | 54.95 | 156.72 | 446.97 | 1,274.84 | 3,636.02 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.05 | -0.23 | -1.09 | -3.74 | -2.82 | -5.78 | -16.49 | -47.02 | -134.11 | -382.51 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.